Social worker Judy Hicks of St. Jude Children's Research Hospital has been named the 2010 Social Worker of the Year by the Association of Pediatric Oncology Social Workers.
A multicenter trial led by investigators from St. Jude Children’s Research Hospital achieved 71 percent survival after three years—20 percent better than previously reported U.S. rates.
Through the annual Volunteen Program at St. Jude Children's Research Hospital, adolescents dedicate their summer vacation to helping children, while learning important lessons.
Motivated clinicians and an Internet connection combined with computers and e-mail access have the power to transform pediatric cancer treatment in the most remote corners of earth.
St. Jude Children’s Research Hospital staff helps investigators gauge the lingering impact of the 1976 vaccine.
St. Jude Children’s Research Hospital investigators have identified childhood cancer survivors who are at increased risk for deteriorating lung health, in part due to the lifesaving bone marrow transplants they underwent years earlier.
Findings from a St. Jude Children's Research Hospital study hold promise for fighting allergies and asthma.
St. Jude Children's Research Hospital explores cancer-fighting potential of body’s own immune cells on both clinical and basic scientific fronts to help children battle cancer.
As physicians nationwide are acknowledged for their talent, sacrifice and courage on National Doctors’ Day, St. Jude Children’s Research Hospital honors its more than 230 staff and consulting physicians who strive to fulfill the hospital’s mission each day.
Investigators believe they have identified the founding member of a chemical family they hope will lead to a new class of cancer drugs, the first designed specifically against a childhood tumor, according to research led by St. Jude Children’s Research Hospital scientists.
Research led by St. Jude Children’s Research Hospital investigators identifies potential new targets for treatment of colitis and other inflammatory bowel diseases.
Multicenter trial led by St. Jude Children’s Research Hospital investigators may change neutropenia treatment for all childhood cancer patients.
A new study led by St. Jude Children's Research Hospital investigators disproves reports that well-fed children are more vulnerable to the dengue virus.
As spring approaches and people return to outdoor activities, caution should be taken in areas of the country that are home to the brown recluse spider.
St. Jude Children’s Research Hospital and Washington University School of Medicine in St. Louis, today announced an unprecedented effort to identify the genetic changes that give rise to some of the world’s deadliest childhood cancers. The team has joined forces to decode the genomes of more than 600 childhood cancer patients treated at St. Jude, who have contributed tumor samples for this historic effort.
New research suggests a family of widely used cholesterol-lowering drugs might help protect individuals from serious illness following bacterial infection, including the pneumococcal infections that pose a deadly threat to those with sickle cell disease.
Charles Sherr, M.D., Ph.D., co-chair of Genetics and Tumor Cell Biology at St. Jude Children’s Research Hospital and a Howard Hughes Medical Institute Investigator, has been awarded the distinction of American Association for the Advancement of Science Fellow.
St. Jude Children’s Research Hospital patients got a head start on the holiday season, and future architect degrees, by helping construct the hospital’s signature gingerbread house with some expert chefs.
As smokers nationwide struggle to quit the habit, St. Jude Children’s Research Hospital is offering assistance to those childhood cancer survivors who need help with smoking cessation.
The lipid that accumulates in brain cells of individuals with an inherited enzyme disorder also drives the cell death that is a hallmark of the disease, according to new research led by St. Jude Children’s Research Hospital investigators.
St. Jude Children’s Research Hospital and the University of Florida Proton Therapy Institute have formed a collaboration to provide proton therapy for St. Jude patients.
Arthur Nienhuis, M.D., of St. Jude Children’s Research Hospital, is the recipient of the 2009 Mentor Award from the American Society of Hematology.
St. Jude Children’s Research Hospital investigators were recently awarded a $23 million federal grant to launch a national study of the drug hydroxyurea to prevent first strokes in children and adolescents with sickle cell anemia (SCA).
St. Jude Children’s Research Hospital has been listed among the top 10 “Best Places to Work in Academia” by The Scientist magazine—this year’s seventh place ranking is the fourth straight year the institution has placed in the top 10.
Research, led by St. Jude, has identified a new chromosomal abnormality in acute lymphoblastic leukemia (ALL) that appears to work in concert with another mutation to give rise to cancer.
Michael Kastan, M.D., Ph.D., and Mary Relling, Pharm.D., of St. Jude Children’s Research Hospital, have been elected to the Institute of Medicine (IOM), a prestigious branch of the National Academy of Sciences.
St. Jude Children’s Research Hospital investigators have discovered how destructive immune cells gain access to insulin-producing cells and help cause diabetes. The finding points to possible new strategies to halt or prevent type I diabetes.
Treatment advances in recent decades mean that the ranks of childhood cancer survivors have swelled to about 325,000 individuals nationwide. St. Jude Children’s Research Hospital has led the field in developing major research programs that follow survivors’ progress for decades after their treatment. The centerpiece of efforts to maintain the long-term health of cancer survivors is the After Completion of Therapy (ACT) Clinic which celebrates its 25th anniversary this year.
St. Jude Children's Research Hospital investigators find that adults who survived cancer as children exercise less, increasing risk of diabetes, obesity and heart disease.
For children and teens with cancer at St. Jude Children's Research Hospital, a team of child life specialists work to manage the stress and anxiety that patients may experience in the hospital setting.
September is National Childhood Cancer Awareness Month, but for researchers at St. Jude Children's Research Hospital it is a year round mission to research new ways to help more children live long, active lives while also working to better understand the challenges childhood cancer survivors face.
Cancer and its treatment causes discomfort on many levels, but controlling pain can speed recovery for children battling the disease, say pain management experts at St. Jude Children's Research Hospital.
For information about a variety of topics related to the H1N1 pandemic, St. Jude has experts available.
Although women treated with chest radiation for childhood cancers constitute one of the highest risk populations for breast cancer, they are far less likely to begin receiving early mammograms when they should, say investigators at St. Jude Children's Research Hospital.
Proper nutrition is important for all children, but especially for those undergoing treatment at St. Jude Children’s Research Hospital.
Scientists at St. Jude Children's Research Hospital have identified inherited variations in two genes that account for 37 percent of childhood acute lymphoblastic leukemia (ALL), including a gene that may help predict drug response.
At least one strain of the H5N1 avian influenza virus leaves survivors at significantly increased risk for Parkinson's disease and possibly other neurological problems later in life, according to new research from St. Jude Children's Research Hospital.
The most comprehensive analysis yet of the genome of childhood acute myeloid leukemia (AML) found only a few mistakes in the genetic blueprint, suggesting the cancer arises from just a handful of missteps, according to new findings from St. Jude Children's Research Hospital.
Switching off a key DNA repair system in the developing nervous system is linked to smaller brain size as well as problems in brain structures vital to movement, memory and emotion, according to new research led by St. Jude Children's Research Hospital scientists.
Researchers have uncovered the first cases in which HIV almost certainly was transmitted from mothers other caregivers to children through pre-chewed food.
The molecular machinery that helps brain cells migrate to their correct place in the developing brain has been identified by scientists at St. Jude Children's Research Hospital.
Childhood acute lymphoblastic leukemia (ALL) can be successfully treated using a carefully personalized chemotherapy regimen without cranial radiation, investigators at St. Jude Children's Research Hospital have found.
A research team has pinpointed a new class of gene mutations, which identify cases of childhood acute lymphoblastic leukemia (ALL) that have a high risk of relapse and death. The finding suggests specific drugs that could treat this high-risk leukemia subtype in children, particularly because such drugs are already in clinical trials for similar blood diseases in adults.
Researchers comparing the fetal development of the eye of the owl monkey with that of the capuchin monkey have found that only a minor difference in the timing of cell proliferation can explain the multiple anatomical differences in the two kinds of eyes.
Cells isolated from the eye that many scientists believed were retinal stem cells are, in fact, normal adult cells, investigators at St. Jude Children's Research Hospital have found.
Scientists from St. Jude Children's Research Hospital and the Children's Oncology Group (COG) have discovered in children with acute lymphoblastic leukemia (ALL) scores of inherited genetic variations that clinicians might be able to use as guideposts for designing more effective chemotherapy for this cancer.
Scientists at St. Jude Children's Research Hospital have teased apart the biological details distinguishing two related neurological diseases — ataxia telangiectasia-like disease (ATLD) and Nijmegen breakage syndrome (NBS).
Scientists at St. Jude Children's Research Hospital have demonstrated a more effective treatment for bacterial pneumonia following influenza. They found that the antibiotics clindamycin and azithromycin, which kill bacteria by inhibiting their protein synthesis, are more effective than a standard first-line treatment with the "beta-lactam" antibiotic ampicillin, which causes the bacteria to lyse, or burst.
Scientists have identified mutations in a gene that predict a high likelihood of relapse in children with acute lymphoblastic leukemia (ALL).
Scientists at St. Jude Children's Research Hospital have answered a central question in cancer biology: whether normal stem cells can give rise to tumors. Stem cells are immature cells that can renew themselves and give rise to mature differentiated cells that compose the range of body tissues. In recent years, researchers have developed evidence that cancers may arise from mutant forms of stem cells.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right